1-(2-(4-(2-ethyl-4,6-dimethylimidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)-3-(4-methylphenyl)sulfonylurea,
grapiprant,
Grapiprant,
415903-37-6,
UNII-J9F5ZPH7NB,
CJ-023423,
CJ 023423,
J9F5ZPH7NB,
RQ-7,
RQ-00000007,
AAT-007,
MR-10A7,
CJ-023,
N-((4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenethyl)carbamoyl)-4-methylbenzenesulfonamide,
Grapiprant [USAN:INN],
Grapiprant (USAN/INN),
CJ-023,423,
SCHEMBL120428,
GTPL5858,
CHEMBL3039498,
DTXSID60194419,
HZVLFTCYCLXTGV-UHFFFAOYSA-N,
BCP20570,
EX-A2544,
BDBM50107283,
ZINC38228051,
AKOS030526811,
CS-5392,
DB12836,
SB18902,
HY-16781,
A15964,
D10638,
CJ-023423; RQ-00000007; AAT-007,
Grapiprant; RQ-00000007; AAT-007; CJ-023423,
1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea,
706802-34-8,
Benzenesulfonamide, N-(((2-(4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)amino)carbonyl)-4-methyl-,
Benzenesulfonamide,N-[[[2-[4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino]carbonyl]-4-methyl-,
N-[([2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino)carbonyl]-4-methylbenzenesulfonamide,
D00IQH,
RQ-00000007 (oral),
AT-001,
MR-10-A-7,
RQ-00000007 (iv),
CID11677589,
CID 11677589,
Grapiprant,415903-37; RQ-00000007; RQ 00000007; RQ00000007; AAT-007; AAT007; AAT 007; Grapiprant,